Among drugs that have been approved in recent years, the average share of females in the trial population has been consistently reported since 2014 by the FDA, with the average share of 51 percent between 2014 and 2021, ranging from 37 percent in 2014 (six trials) to 57.1 percent in 2019
Vekovischeva OY, Zamanillo D, Echenko O, Seppala T, Uusi-Oukari M, Honkanen A et al (2001)
Research has confirmed no effect on serum IGF-1 and no negative impact on glucose metabolism
Peptides like BPC-157 and TB-500 are typically sold for research purposes only and are not approved by the FDA for direct patient or human treatment
Analysis included measurement of biochemical parameters and an assessment of sense of well-being compared with 10 other patients with cirrhosis not administered GSH
Immune Function : Glutathione supports the immune system, helping to fend off illnesses